VolitionRx Limited (VNRX) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 2.46M USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $2.46M | (m) | (m) |
| 2026-03-31 | (m) | $2.47M | (m) | (m) |
| 2025-12-31 | (m) | $1.73M | (m) | (m) |
| 2025-09-30 | (m) | $1.47M | (m) | (m) |
| 2025-06-30 | (m) | $1.32M | (m) | (m) |
| 2025-03-31 | (m) | $1.31M | (m) | (m) |
| 2024-12-31 | (m) | $1.23M | (m) | (m) |
| 2024-09-30 | (m) | $1.29M | (m) | (m) |
| 2024-06-30 | (m) | $976.52K | (m) | (m) |
| 2024-03-31 | (m) | $797.03K | (m) | (m) |
| 2023-12-31 | (m) | $775.30K | (m) | (m) |
| 2023-09-30 | (m) | $651.04K | (m) | (m) |
| 2023-06-30 | (m) | $518.55K | (m) | (m) |
| 2023-03-31 | (m) | $341.99K | (m) | (m) |
| 2022-12-31 | (m) | $306.39K | (m) | (m) |
| 2022-09-30 | (m) | $200.92K | (m) | (m) |
| 2022-06-30 | (m) | $193.69K | (m) | (m) |
| 2022-03-31 | (m) | $178.72K | (m) | (m) |
| 2021-12-31 | (m) | $90.03K | (m) | (m) |
| 2021-09-30 | (m) | $82.92K | (m) | (m) |
| 2021-06-30 | (m) | $58.01K | (m) | (m) |
| 2021-03-31 | (m) | $38.42K | (m) | (m) |
| 2020-12-31 | (m) | $13.43K | (m) | (m) |
| 2020-09-30 | (m) | $6.31K | (m) | (m) |
| 2020-06-30 | (m) | $22.83K | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $17.10K | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $14.79K | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $54.97K | (m) | (m) |
| 2012-09-30 | (m) | $54.97K | (m) | (m) |
| 2012-06-30 | (m) | $27.38K | (m) | (m) |
| 2012-03-31 | (m) | $15.67K | (m) | (m) |
| 2011-12-31 | (m) | $0.00 | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |